Report of the 19th follow-up survey of primary liver cancer in Japan

Masatoshi Kudo, Namiki Izumi, Takafumi Ichida, Yonson Ku, Norihiro Kokudo, Michiie Sakamoto, Tadatoshi Takayama, Osamu Nakashima, Osamu Matsui, Yutaka Matsuyama

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The 19th Nationwide Follow-up Survey of Primary Liver Cancer in Japan comprised 20850 primary liver cancer patients newly registered at 482 medical institutions over a period of 2 years (from 1 January 2006 to 31 December 2007). Of these, 94.7% had hepatocellular carcinoma (HCC) and 4.4% had intrahepatic cholangiocarcinoma (ICC). In addition, follow-up data were obtained regarding 34752 patients who were registered in the previous survey. Epidemiological and clinicopathological factors, diagnosis, and treatment were examined in newly registered patients. Compared with the 18th follow-up survey, the present follow-up survey suggested an increase in the number of elderly and female patients, a reduction in the number of hepatitis B surface antigen- and anti-hepatitis C virus antibody-positive patients, and a reduction in tumor size at the time of clinical diagnosis. In terms of local ablation therapy, the number of patients receiving radiofrequency ablation therapy increased. The cumulative survival rates for newly registered patients between 1996 and 2007 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified according to background factors and treatments. The cumulative survival rates of newly registered patients between 1978 and 2007 were calculated after dividing individuals into groups according to registration date (1978-1987, 1988-1997, and 1998-2007). The data obtained from this follow-up survey will contribute to the medical management of primary liver cancer and facilitate future research.

Original languageEnglish
Pages (from-to)372-390
Number of pages19
JournalHepatology Research
Volume46
Issue number5
DOIs
Publication statusPublished - 2016 Mar 1
Externally publishedYes

Fingerprint

Liver Neoplasms
Japan
Cholangiocarcinoma
Hepatocellular Carcinoma
Survival Rate
Hepatitis C Antibodies
Surveys and Questionnaires
Therapeutics
Hepatitis B Surface Antigens
Neoplasms

Keywords

  • Combined hepatocellular and cholangiocarcinoma
  • Cumulative survival rate
  • Follow-up survey
  • Hepatocellular carcinoma
  • Intrahepatic cholangiocarcinoma

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Kudo, M., Izumi, N., Ichida, T., Ku, Y., Kokudo, N., Sakamoto, M., ... Matsuyama, Y. (2016). Report of the 19th follow-up survey of primary liver cancer in Japan. Hepatology Research, 46(5), 372-390. https://doi.org/10.1111/hepr.12697

Report of the 19th follow-up survey of primary liver cancer in Japan. / Kudo, Masatoshi; Izumi, Namiki; Ichida, Takafumi; Ku, Yonson; Kokudo, Norihiro; Sakamoto, Michiie; Takayama, Tadatoshi; Nakashima, Osamu; Matsui, Osamu; Matsuyama, Yutaka.

In: Hepatology Research, Vol. 46, No. 5, 01.03.2016, p. 372-390.

Research output: Contribution to journalArticle

Kudo, M, Izumi, N, Ichida, T, Ku, Y, Kokudo, N, Sakamoto, M, Takayama, T, Nakashima, O, Matsui, O & Matsuyama, Y 2016, 'Report of the 19th follow-up survey of primary liver cancer in Japan', Hepatology Research, vol. 46, no. 5, pp. 372-390. https://doi.org/10.1111/hepr.12697
Kudo, Masatoshi ; Izumi, Namiki ; Ichida, Takafumi ; Ku, Yonson ; Kokudo, Norihiro ; Sakamoto, Michiie ; Takayama, Tadatoshi ; Nakashima, Osamu ; Matsui, Osamu ; Matsuyama, Yutaka. / Report of the 19th follow-up survey of primary liver cancer in Japan. In: Hepatology Research. 2016 ; Vol. 46, No. 5. pp. 372-390.
@article{99b4a2948899450aadefad2125014f5c,
title = "Report of the 19th follow-up survey of primary liver cancer in Japan",
abstract = "The 19th Nationwide Follow-up Survey of Primary Liver Cancer in Japan comprised 20850 primary liver cancer patients newly registered at 482 medical institutions over a period of 2 years (from 1 January 2006 to 31 December 2007). Of these, 94.7{\%} had hepatocellular carcinoma (HCC) and 4.4{\%} had intrahepatic cholangiocarcinoma (ICC). In addition, follow-up data were obtained regarding 34752 patients who were registered in the previous survey. Epidemiological and clinicopathological factors, diagnosis, and treatment were examined in newly registered patients. Compared with the 18th follow-up survey, the present follow-up survey suggested an increase in the number of elderly and female patients, a reduction in the number of hepatitis B surface antigen- and anti-hepatitis C virus antibody-positive patients, and a reduction in tumor size at the time of clinical diagnosis. In terms of local ablation therapy, the number of patients receiving radiofrequency ablation therapy increased. The cumulative survival rates for newly registered patients between 1996 and 2007 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified according to background factors and treatments. The cumulative survival rates of newly registered patients between 1978 and 2007 were calculated after dividing individuals into groups according to registration date (1978-1987, 1988-1997, and 1998-2007). The data obtained from this follow-up survey will contribute to the medical management of primary liver cancer and facilitate future research.",
keywords = "Combined hepatocellular and cholangiocarcinoma, Cumulative survival rate, Follow-up survey, Hepatocellular carcinoma, Intrahepatic cholangiocarcinoma",
author = "Masatoshi Kudo and Namiki Izumi and Takafumi Ichida and Yonson Ku and Norihiro Kokudo and Michiie Sakamoto and Tadatoshi Takayama and Osamu Nakashima and Osamu Matsui and Yutaka Matsuyama",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/hepr.12697",
language = "English",
volume = "46",
pages = "372--390",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "5",

}

TY - JOUR

T1 - Report of the 19th follow-up survey of primary liver cancer in Japan

AU - Kudo, Masatoshi

AU - Izumi, Namiki

AU - Ichida, Takafumi

AU - Ku, Yonson

AU - Kokudo, Norihiro

AU - Sakamoto, Michiie

AU - Takayama, Tadatoshi

AU - Nakashima, Osamu

AU - Matsui, Osamu

AU - Matsuyama, Yutaka

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The 19th Nationwide Follow-up Survey of Primary Liver Cancer in Japan comprised 20850 primary liver cancer patients newly registered at 482 medical institutions over a period of 2 years (from 1 January 2006 to 31 December 2007). Of these, 94.7% had hepatocellular carcinoma (HCC) and 4.4% had intrahepatic cholangiocarcinoma (ICC). In addition, follow-up data were obtained regarding 34752 patients who were registered in the previous survey. Epidemiological and clinicopathological factors, diagnosis, and treatment were examined in newly registered patients. Compared with the 18th follow-up survey, the present follow-up survey suggested an increase in the number of elderly and female patients, a reduction in the number of hepatitis B surface antigen- and anti-hepatitis C virus antibody-positive patients, and a reduction in tumor size at the time of clinical diagnosis. In terms of local ablation therapy, the number of patients receiving radiofrequency ablation therapy increased. The cumulative survival rates for newly registered patients between 1996 and 2007 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified according to background factors and treatments. The cumulative survival rates of newly registered patients between 1978 and 2007 were calculated after dividing individuals into groups according to registration date (1978-1987, 1988-1997, and 1998-2007). The data obtained from this follow-up survey will contribute to the medical management of primary liver cancer and facilitate future research.

AB - The 19th Nationwide Follow-up Survey of Primary Liver Cancer in Japan comprised 20850 primary liver cancer patients newly registered at 482 medical institutions over a period of 2 years (from 1 January 2006 to 31 December 2007). Of these, 94.7% had hepatocellular carcinoma (HCC) and 4.4% had intrahepatic cholangiocarcinoma (ICC). In addition, follow-up data were obtained regarding 34752 patients who were registered in the previous survey. Epidemiological and clinicopathological factors, diagnosis, and treatment were examined in newly registered patients. Compared with the 18th follow-up survey, the present follow-up survey suggested an increase in the number of elderly and female patients, a reduction in the number of hepatitis B surface antigen- and anti-hepatitis C virus antibody-positive patients, and a reduction in tumor size at the time of clinical diagnosis. In terms of local ablation therapy, the number of patients receiving radiofrequency ablation therapy increased. The cumulative survival rates for newly registered patients between 1996 and 2007 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified according to background factors and treatments. The cumulative survival rates of newly registered patients between 1978 and 2007 were calculated after dividing individuals into groups according to registration date (1978-1987, 1988-1997, and 1998-2007). The data obtained from this follow-up survey will contribute to the medical management of primary liver cancer and facilitate future research.

KW - Combined hepatocellular and cholangiocarcinoma

KW - Cumulative survival rate

KW - Follow-up survey

KW - Hepatocellular carcinoma

KW - Intrahepatic cholangiocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=84966546678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966546678&partnerID=8YFLogxK

U2 - 10.1111/hepr.12697

DO - 10.1111/hepr.12697

M3 - Article

VL - 46

SP - 372

EP - 390

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 5

ER -